关于本次论坛
2026 KIIDD 学术论坛于 2026 年 10 月 12–14 日在香港中文大学（深圳）校园举办，由医学院科比尔卡创新药物研发研究院（KIIDD）主办。
2026 KIIDD 学术论坛
2026 KIIDD 学术论坛于 10 月 12–14 日在香港中文大学（深圳）举办，由科比尔卡创新药物研发研究院（KIIDD）主办。会议聚焦膜蛋白生物学与治疗创新，涵盖 GPCR、离子通道、结构生物学方法及药物研发新方向。 本页保留本届论坛的概况与学术主题。会议已结束，相关照片和最终日程可在活动回顾中查阅。
关于 KIIDD
Established on April 10, 2017, at The Chinese University of Hong Kong, Shenzhen, the Kobilka Institute of Innovative Drug Discovery (KIIDD) is named in honor of 2012 Nobel Laureate in Chemistry, Professor Brian K. Kobilka, recognizing his groundbreaking work on G protein-coupled receptors. Bolstered by significant government funding, KIIDD has cultivated a world-class research ecosystem featuring the Kobilka Cryo-Electron Microscopy Center (KEMC), the Advanced Mass Spectrometry facility (KMS), and other cutting-edge platforms. Our multidisciplinary team is dedicated to discovering novel therapeutics for challenging membrane protein targets, including complex receptors and transporters. Beyond pioneering research, KIIDD serves as a dynamic nexus connecting academia, biotechnology, and the pharmaceutical industry. Through targeted symposia and collaborative initiatives, we unite global experts to share knowledge and accelerate the development of life-saving treatments for unmet medical needs.
关于 KEMC
The Kobilka Cryo-Electron Microscopy Center (KEMC), operated by the Kobilka Institute of Innovative Drug Discovery (KIIDD) and funded by the Shenzhen Municipal and Longgang District Governments, stands as a premier high-performance biomedical imaging platform dedicated to accelerating structural biology and drug discovery. Equipped with world-class instrumentation—including two 300kV Titan Krios G3i systems, a 120kV Talos 120C, and advanced data processing infrastructure—KEMC delivers atomic-resolution insights into biological macromolecules and membrane proteins, serving as an indispensable engine for innovation. Since launching its shared service initiative in 2021, the Center has empowered over 30 external research institutes and biopharmaceutical enterprises, fostering deep collaborations with global top-tier universities to drive scientific breakthroughs. we warmly invite researchers and industry partners from around the world to visit, collaborate, and leverage our state-of-the-art facilities to shape the future of medicine.